Tracheal Eccentricity is Associated with Respiratory Morbidity and Mortality in Chronic Obstructive Pulmonary Disease
Aguilera, S. M.; Sthanam, V.; Chaudhary, M. F. A.; Nakhmani, A.; Reinhardt, J.; Bhatt, S. P.; Bodduluri, S.
Show abstract
Background: Chronic obstructive pulmonary disease (COPD) is characterized by airway remodeling, which may extend to the central airways and alter tracheal morphology. Whether tracheal shape relates to disease severity, quality of life, functional capacity, or survival is not established. Objective: To determine whether CT-derived tracheal lumen eccentricity is associated with cross-sectional and longitudinal clinical outcomes in COPD. Methods: We analyzed 8,383 participants from the multicenter COPDGene study. At each axial cross-section of the trachea, lumen eccentricity ({epsilon}) was computed from the major and minor axis lengths, and the participant-level value was taken as the arithmetic mean across all tracheal slices; {epsilon} = 0 denotes a circular lumen and values approaching 1 denote progressively elongated ellipses. Baseline outcomes were spirometry, 6-minute walk distance (6MWD), St. George's Respiratory Questionnaire (SGRQ) total score, and modified Medical Research Council (mMRC) dyspnea score. Longitudinal outcomes were annualized change in FEV1 and all-cause mortality. Multivariable linear and Cox proportional hazards models were adjusted for [age, sex, race, BMI, smoking status, pack-years, scanner model]. Results: Tracheal eccentricity rose monotonically with severity of airflow obstruction (0.60{+/-}0.07, 0.61{+/-}0.07, 0.62{+/-}0.07, 0.64{+/-}0.08, and 0.64{+/-}0.08 in GOLD stages 0 through 4, respectively). Higher eccentricity was independently associated with lower FEV1 ({beta} = -0.30 L, 95% CI -0.47 to -0.14; p < 0.001), lower FEV1/FVC ({beta} = -0.06, 95% CI -0.09 to -0.04; p < 0.001), shorter 6MWD ({beta} = -15.7 m, 95% CI -25.2 to -6.2; p = 0.001), higher SGRQ score ({beta} = 16.9, 95% CI 11.2 to 22.5; p < 0.001), higher mMRC dyspnea score ({beta} = 0.4, 95% CI 0.1 to 0.6; p = 0.007), and accelerated lung function decline ({beta} = -23.8 mL/year, 95% CI -45.13 to -2.48; p = 0.029). Eccentricity was also associated with all-cause mortality (adjusted HR 1.81, 95% CI 1.01 to 3.26; p = 0.047). Conclusions: Tracheal lumen eccentricity is associated with worse quality of life, reduced functional capacity, accelerated lung function decline, and mortality in COPD, supporting central airway morphology as a candidate imaging biomarker.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- The protective effect of club cell secretory protein (CC-16) on COPD risk and progression: a Mendelian randomisation study 93%
- Circulating CTHRC1 Levels are Associated with IPF Disease Severity and Survival 92%
- Optimised oxygenation improves functional capacity during daily activities in patients with COPD on long-term oxygen therapy – a randomised crossover trial 92%
Similar papers in this journal
- COPD in the time of COVID-19: An analysis of acute exacerbations and reported behavioural changes in patients with COPD 94%
- Sputum microbiome α-diversity is a key feature of the COPD frequent exacerbator phenotype 93%
- Development and validation of a parent proxy bronchiectasis child quality of life instrument: The BC-QoL 90%
Similar papers in this journal
- The Effect of a Post-Bronchodilator FEV 1 /FVC < 0.7 on COPD Diagnosis and Treatment: A Regression Discontinuity Design 92%
- Biomarkers of collagen synthesis predict progression in the PROFILE idiopathic pulmonary fibrosis cohort 92%
- Perfusion imaging heterogeneity during NO inhalation distinguishes pulmonary arterial hypertension (PAH) from healthy subjects and has potential as an imaging biomarker 92%
Similar papers in this journal
- Clustering-based COPD Subtypes Have Distinct Longitudinal Outcomes and Multi-omics Biomarkers 94%
- Two-way remote monitoring allows effective and realistic provision of home-NIV to COPD patients with persistent hypercapnia 92%
- Relative Contributions of Family History and a Polygenic Risk Score on COPD and Related Outcomes: COPDGene and ECLIPSE studies 91%
Similar papers in this journal
- Spirometric classifications of COPD severity as predictive markers for clinical outcomes: the HUNT Study 93%
- Domiciliary high-flow nasal cannula oxygen therapy for stable hypercapnic COPD patients: a prospective, multicenter, open-label, randomized controlled trial 93%
- Blood-Based Transcriptomic and Proteomic Biomarkers of Radiologic Emphysema 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.